Company news

Standard BioTools Inc. news in 2026

Standard BioTools Inc.'s news releases, calls and decks from 2026, newest first.

View company

ARCHIMED Life Science Tools & Services Completes Acquisition of Standard BioTools’ Microfluidics Business, Now Biomark Scientific

November 3, 2026

Standard BioTools Announces Agreement to Sell Microfluidics Business to ARCHIMED

October 5, 2026

Standard BioTools Provides Update on Sale of Mass Cytometry Business

September 30, 2026

Standard BioTools: Q2 Earnings Snapshot

August 5, 2026

Standard BioTools Reports Second Quarter 2026 Financial Results

August 5, 2026

Standard BioTools Announces Sale of Mass Cytometry Business and Illumina’s Buyout of Contingent Payments to Advance Merger with Treeline Biosciences

July 28, 2026

Standard BioTools to Announce Second Quarter 2026 Financial Results on August 5, 2026

July 22, 2026

Standard BioTools Announces Filing of Registration Statement in Connection with Treeline Biosciences Transaction

July 20, 2026

Standard BioTools and Treeline Biosciences Announce Merger Agreement

June 7, 2026

Standard BioTools Reports First Quarter 2026 Financial Results

May 5, 2026

Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026

April 21, 2026

Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026

Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 10, 2026

Standard BioTools Completes Sale of SomaLogic to Illumina

January 30, 2026

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue

January 8, 2026

Decks in 2026